EXUMA BIOTECH
EXUMA Biotech is a clinical-stage biotechnology company discovering and developing Chimeric Antigen Receptor (CAR)-T cell products for solid tumors. They develop new tools for the patient’s immune system to fight various solid tumor malignancies, such as renal cell carcinoma, soft tissue sarcoma, gastric cancer, and others. It was founded in 2015 and headquartered in Grand Cayman, Midland.
EXUMA BIOTECH
Industry:
Big Data Biotechnology Health Care Medical
Founded:
2015-01-01
Address:
Grand Cayman, Midland, Cayman Islands
Country:
Cayman Islands
Website Url:
http://www.exumabio.com
Total Employee:
11+
Status:
Active
Contact:
1-345-232-0566
Email Addresses:
[email protected]
Total Funding:
107 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Abexxa Biologics
Abexxa Biologics is a biopharmaceutical company that focuses on discovering and developing breakthrough antibody-based drugs.
Renovare Environmental
Renovare Environmental uses Green Technology and Big Data to dispose of organic waste, cut costs, and drive sustainability.
Cytrellis Biosystems
Cytrellis is a medical technology company that develops aesthetic devices.
Garner Health
Garner Health is a technology-driven platform providing healthcare services and helping people search for doctors.
Aitia
Leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs
MedAnswers
A health tech company disrupting how those struggling to conceive access specialty fertility care through the best of science and tech.
AOBiome
AOBiome is a life sciences company that focuses on transforming human health.
OM1
OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.
Orchid
Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders.
Valo Health
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
Y-mAbs Therapeutics
YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Americo Financial Life and Annuity
Americo Financial Life and Annuity investment in Series B - Exuma Biotech
MSD Partners
MSD Partners investment in Series B - Exuma Biotech
F1 BioVentures
F1 BioVentures investment in Series B - Exuma Biotech
Shanghai Sinobioway Sunterra Biotechnology
Shanghai Sinobioway Sunterra Biotechnology investment in Venture Round - Exuma Biotech
Sinobioway Group
Sinobioway Group investment in Series A - Exuma Biotech
BioAtla
BioAtla investment in Series A - Exuma Biotech
F1 BioVentures
F1 BioVentures investment in Series A - Exuma Biotech
SunTerra Capital
SunTerra Capital investment in Series A - Exuma Biotech
Official Site Inspections
http://www.exumabio.com Semrush global rank: 10.27 M Semrush visits lastest month: 14
- Host name: web2.axxiem.com
- IP address: 34.230.198.252
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Exuma Biotech"
Our Company - EXUMA Biotech
Vice President of Finance & Controller. Mr. Yan is a certified public accountant with over 25 years of experience in finance & accounting. He joined EXUMA Biotech in 2017 and currently serves as its Vice President of Finance & …See details»
Exuma Biotech - Crunchbase Company Profile & Funding
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.See details»
EXUMA Biotech Corp. - Drug pipelines, Patents, Clinical trials
For more information, visit exumabio.com and connect with us on LinkedIn and Twitter (@ExumaBiotech). Contact: Gregory R. Wade, Ph.D. Chief Business Officer & Head of …See details»
Press Releases & Mentions - exumabio.com
Mar 12, 2020 Additionally, the company has now aligned management with its international subsidiaries under one cohesive global organization (www.exumabio.com), to better reflect its …See details»
EXUMA Biotech - LinkedIn
EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market cell & gene therapies for the treatment of cancer. Founded in 2015, The company has rapidly built its core ...See details»
EXUMA Biotech - LinkedIn
EXUMA Biotech | 1,700 followers on LinkedIn. EXUMA Biotech is a clinical-stage biotechnology company committed to bringing to market cell & gene therapies for the treatment of cancer. …See details»
F1 Oncology Changes Name To EXUMA Biotech; …
Mar 12, 2020 Additionally, the company has now aligned management with its international subsidiaries under one cohesive global organization (www.exumabio.com), to better reflect its new business model. "We ...See details»
Exuma Biotech - Craft
West Palm Beach, FL HQ. United States. 625 N Flagler Dr #625. Sacramento, CA. United States. 400 R St. George Town, George Town. Cayman Islands. Strathvale House, 90 N Church StSee details»
Exuma Biotech CEO and Key Executive Team | Craft.co
Exuma Biotech's Chairman & CEO is Gregory Frost. Other executives include Sid Kerkar, VP Oncology, Research & Development; Wendy Zhang, VP Alliance Operations, Shanghai and 5 …See details»
EXUMA Biotech Presents Early Clinical and Translational Findings …
Apr 17, 2023 For more information, visit exumabio.com and connect with us on LinkedIn and Twitter (@ExumaBiotech). Contact: Gregory R. Wade, Ph.D. Chief Business Officer & Head of …See details»
March 12, 2020 - exumabio.com
Cohesive global organization (www.exumabio.com), to better reflect its new business model. “We are ... exumabio.com. Media Contact: Susan Roberts (202) 779-0929 sr@roberts …See details»
EXUMA Biotech Completes Series B2 to Advance Novel Cell
WEST PALM BEACH, Fla., Dec. 21, 2021 /PRNewswire/ -- EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene therapies and …See details»
EXUMA Biotech Completes Series B2 to Advance Novel Cell
WEST PALM BEACH, Fla., Dec. 21, 2021 /PRNewswire/ -- EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene therapies and …See details»
EXUMA Biotech Completes Series B2 to Advance Novel Cell
WEST PALM BEACH, Fla., Dec. 21, 2021 /PRNewswire/ -- EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene therapies and …See details»
EXUMA Biotech Completes Series B2 to Advance Novel Cell
West Palm Beach, Fl., – December 21st, 2021- EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene therapies and delivery …See details»
F1 Oncology Changes Name To EXUMA Biotech; Announces New …
Mar 12, 2020 WEST PALM BEACH, Fla., March 12, 2020 /PRNewswire/ -- EXUMA Biotech Corp. (formerly F1 Oncology), a clinical-stage biotechnology company discovering and …See details»
How Big Data Is Accelerating EXUMA Biotech In The Race To …
Aug 3, 2020 <p>In pre-clinical studies using a modified lentiviral vector—whereby T cell genes are modified using a lentivirus—EXUMA Biotech has demonstrated that …See details»
Press Releases & Mentions - exumabio.com
Apr 17, 2023 WEST PALM BEACH, Fla., April 17, 2023 — EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for …See details»
Our Science - EXUMA Biotech
In 2015, EXUMA initiated ambitious efforts to discover platform technologies that could enablecell and gene therapies to deliver their full potential to patients. EXUMA’s Platforms may Enhance …See details»